Creative Details

Quality Score: 7/10

The advertisement promotes TremfyA (guselkumab), an IL-23 blocker for treating Crohn's disease, highlighting its dosing options and providing safety information.

Creative Information

CID:3224e46b-73dd-445a-875f-ea7e8b4be307
CRID:25_h1yg3aaw
Domain:tremfya.com
Seat:TTD
Size:300x250
Bid:$1.43
Timestamp:11/13/2025, 2:49:04 PM
Declared IAB Categories:

    Analysis

    5 succeeded(100% complete)
    TaskStatusLast UpdatedDurationActions
    ad_analysissuccess11/13/2025, 3:54:28 PM7.58s
    adomain_analysissuccess12/10/2025, 1:44:56 AM10.39s
    adomain_capturesuccess11/13/2025, 6:37:14 PM0.23s
    ad_rendersuccess11/13/2025, 3:54:21 PM18.58s
    brand_mappingsuccess11/13/2025, 2:49:04 PM0.09s

    Analysis Results

    Ad Format: banner

    Brands: Tremfya

    Sensitive:Pharmaceutical Products
    Size:300x250
    Data Transferred:1276.17 KB
    Render Time:8.52 Seconds
    Creative Inferred IAB Categories:
    • Health & Fitness (IAB7)
    • Society (IAB14)
    Creative Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Domain Inferred IAB Categories:
    • Health & Fitness (IAB7)
    Domain Inferred IAB Ad Products:
    • Health and Medical Services (1378)
    • Pharmaceuticals (1473)
    Landing Page:
    Total Ad Size:1295.76 KB
    Requests Made:
    URLSize (KB)
    https://static.adsafeprotected.com/main.19.8.619.js269.79
    https://pagead2.googlesyndication.com/pagead/managed/js/activeview/current/ufs_web_display.js222.95
    https://s0.2mdn.net/879366/express_html_inpage_rendering_lib_200_287.js116.69
    https://ad.doubleclick.net/ddm/adj/N2561878.2783400HEALTHUNION.COM/B33412659.418029803;dc_ver=106.314;sz=300x250;u_sd=1;gdpr=0;nel=1;dc_adk=2027040026;ord=l38wi5;click=https%3A%2F%2Finsight.adsrvr.org%2Ftrack%2Fclk%3Fimp%3Ddbe0b102-6265-41b8-99bd-8df42e955f58%26ag%3Df4k1leb%26sfe%3D1b4ca7d6%26sig%3Dw5unbJl9jwHytDHNIvRYhSjQFYJQXhyFW7GgIyEYoYI.%26crid%3Dh1yg3aaw%26cf%3D9668047%26fq%3D0%26t%3D1%26td_s%3Dwww.newsweek.com%26rcats%3Djte%2Cy29%2C5rf%26mste%3Dwww.newsweek.com%26mfld%3D3%26mssi%3D%26mfsi%3D%26sv%3Dkargo%26uhow%3D91%26agsa%3D%26wp%3D1.4285715%26rgz%3D28270%26dt%3DMobile%26osf%3DAndroid%26os%3DAndroid160%26br%3DChrome%26svpid%3D8565%26rlangs%3Den%26mlang%3D%26did%3D%26rcxt%3DMobileOptimizedWeb%26tmpc%3D14.650000000000034%26vrtd%3D%26osi%3D%26osv%3D%26daid%3D%26dnr%3D0%26vpb%3D%26crrelr%3D%26npt%3D2%26cc%3D2~KLUv_WMdqREMNQRdGQBDZIO4XFtUbk1Uji0qx4XBy-WGZblAA11iDqBSYbst0gOAHKocgjfPQEWoXHVvRagYe8VjAmI1jBJIaTjRcH79mcI97NjxGhfl4G1BwYDoARaOyiQyVlVJHZnzCqN9JcPAptDcGLXiO1NXtgXaTWP9--UiHcWhPuIT6RO_smO9UykEc-a_MuqSyJV-Han-LEwqmTpXMZc2x2y67CuK3aHFyh2ZGO3j2nGN0__38iL7AgP2U7-otblGYVjtvNF-sDMrfQ1msV87uCp87mA0tJg7hVqvzzC6eZfBPOzvKsYk4mhKJprxOnbPujBm00hmBtXdXU4fGvXyqXqUrM7DzvhcLMhVG4VhU9jnZEabWKQUiP-WSd6-CrmCPKws3MloIDfsV5oBy7DVIVjvhURObSgZEev_P3ym947RXRexDkPj8mEtELksWrlX5i41Yr2yyakz2EQio16xjDRLotHZH7YiNGKtCW4k2YdFoKsPEeSZtuesD63-v8_k9T2n-R7_d5nX1fJd07986_48r3X0j2vN-XPn6gaERpBHRLQ86rPFKsIcHnQu5VFLE_8wscOhYxKuLcmMs9Y4jXBs2qW2jp1wbdc4fPcUJND7Orquf11911pcUFBKy-r6nNzGkSHHa4GlSUiEu--Mm_RfxStD47FliUaYH--Oy-73EVQFp8--__cwDct4H3d4x2TleRWLhfVO_F5EKS9glQPynaGTh-iD77yHQkNQKJiTBodIrjcRc4jd4w9h8YZ0UE4aTSDtNuyDS4clGxSSmrg_xq1p6j_xKmx3PJoOVdn2hNYUi07K7JkUM-xH5tKrHUHZDYYOXdNkIZVsLzNpJoK9tHwzZp-qVnOAHnRDByzgpOmeWjOktb0uXUI8rAlRI2I-aMNguUg0tkN2Ci_MpMn8M3k8_KK2dPutTWJBjgsGTtN6kBA_5IsHJp80X8I9gFWsTG4QzF6zlWDcWHOBljaYZKDsH5D8ryPBi2E88zsPtc-ZWptKHc5kb20xk1hbW0nWYarPJiRKtWUgp5tJS1HCniUtsq9nHj0CHtgfeZkhZnMldFd5lQbTyWNCn1gnSIYN%26dur%3D1~KLUv_WMFoCgkjgD1AgAThA0WeAMJDPioLrDCcgXCHF7H22Ev9fQa-o4prJpviPu9_soIBR0etPEotwJhjq0zJRV9_JRpOAEL_Mw27Km6vj517MgXnHUNIJWkC-Ls_-ZJj1JffSrBDX7cgk8Q%26durs%3D3AGH1U%26bdc%3D131%26uidd%3Dfw4_gYQ21PoQQkGlqgwPvMpbjuztLiQFx0eJ_T5KOAoNCaZ0%26idl%3DXY3007GffevKWn6qQQPdSIsvXFYhfTzF4WbH2vBGJHu6cgiEw%26mk%3DSamsung%26mdl%3DSM-A156U%26testid%3Diavc1%2520%26fpa%3D714%26pcm%3D3%26ict%3DWiFi%26said%3D8fb63274-5e98-493a-ac9f-72f9707245de%26auct%3D1%26us_privacy%3D1---%26tail%3D1%26r%3D;uach=WyIiLCIiLCIiLCIiLCIiLG51bGwsMCxudWxsLCIiLG51bGwsMF0.;dc_rfl=1,https%3A%2F%2Fecho-server.dangoldin.workers.dev%2F$0;xdt=0;crlt=!8(4JEeQWf;gcsr=m;stc=1;chaa=1;sttr=45;prcl=s107.43
    https://static.adsafeprotected.com/sca.17.6.4.js91.43
    https://www.googletagservices.com/dcm/impl_v106.js68.78
    https://pixel.adsafeprotected.com/rjss/st/2064289/79600518/skeleton.js?ias_advertiserId=0l15xix&ias_campId=d5tw1jg&ias_placementId=f4k1leb&ias_creativeId=h1yg3aaw&ias_chanId=kargo&ias_pubId=8565&bidurl=www.newsweek.com%2fjeffrey-epsteins-brother-mark-responds-to-new-trump-emails-11036432&ias_impId=dbe0b102-6265-41b8-99bd-8df42e955f58&ias_dealId=&ias_xappb=www.newsweek.com&ias_dspID=9&adsafe_par63.54
    https://fw.adsafeprotected.com/rjss/st/2432107/86465375/skeleton.js?bundleid=INSERTMACROHERE62.23
    https://s0.2mdn.net/ads/studio/cached_libs/gsap_3.2.4_min.js57.35
    https://ep1.adtrafficquality.google/bg/DPVnEqOOr8GEkyz-5oBqyWDy70NS1PVNM5rSU7EcCeQ.js52.04

    Advertiser Domain

    Advertiser Domain

    Ad Preview

    Landing Page

    Landing Page

    Creatives

    Creative Screenshot 1Creative Screenshot 2